Sanofi-Aventis obtained billions of dollars in increased revenues at the expense of unwary cancer victims simply hoping to survive their condition and return to a normal life.
FDA & Prescription Drugs
Xarelto has been connected to an increased number of uncontrollable bleeding events, primarily because there is no approved antidote for patients who use the medication, and many of the side effects associated with the drug have been particularly serious because the bleeding cannot be successfully controlled.
The U.S. Supreme Court allowed to stand an appellate court decision stating that a product manufacturer is subject to personal jurisdiction for product-related claims in a state where development or testing occurred, dealing a huge blow to the well-funded big pharma legal teams who may well now find themselves defending their drugs and medical devices in all fifty states.
A stunning FDA recall letter dated April 7, 2017 to Jay Borneman, CEO of Hyland’s, lays out shockingly strong warnings and statements about Hyland’s dangerous teething products. The FDA stated a recall was necessary because "there is a reasonable probability that the use [of teething tablets]...will cause serious adverse event health consequences or death."
Deregulation and Budget Cuts Likely to Lead to Increased Adverse Event Reporting in Pharmaceutical Industry
With deregulation of FDA oversight, cuts in funding to institutions conducting government research and overview, and the potential for essentially the privatization of the FDA because of increased industry funding, it is likely we will see an increase in injuries and thus adverse event reports
For all of these reasons, it is imperative that consumers understand that the need to report drug injuries or side effects is great. Reports are a critical way the FDA can detect injuries or side effects early and prevent it from unnecessarily happening to others
Approximately 28 morcellator lawsuits have been transferred to the U.S. District Court for the District of Kansas as part of a multidistrict litigation (MDL) consolidation.…
Responding to numerous reports of patients who had either died or had to undergo a liver transplant after receiving two hepatitis C medications, the U.S.…
A report recently released by the U.S. Food and Drug Administration (FDA) concludes that fluoroquinolones are no more effective at treating sinus infections, bronchitis in…